Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9567402
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
granted -
US 9565840
Fibrotic non-human animal, and use thereof
granted -
US 9561256
LLP2A-bisphosphonate conjugates for osteoporosis treatment
granted -
US 9556131
Compositions, methods of use, and methods of treatment
granted -
US 9555100
Herpes virus vaccine and methods of use
granted -
US 9555114
Methods for in vivo drug delivery with porous nanostructures
granted -
US 9555073
Use of vitelline protein B as a microencapsulating additive
granted -
US 9555159
Inorganically surface-modified polymers and methods for making and using them
granted -
US 9549954
Method and composition for inducing human pluripotent stem cells
granted -
US 9549905
Treatment of inflammatory and infectious skin disorders
granted -
US 9550827
Methods for ameliorating and preventing central nervous system inflammation
granted -
US 9551722
Amyloid binding agents
granted -
US 9546193
Compositions and methods for 18F-fluorodeoxyglycosylamines
granted -
US 9545422
Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to subcellular regions of retinal ganglion cells
granted -
US 9545461
Anti-microbial peptides and methods of use thereof
granted -
US 9539321
HMGB1-derived peptides enhance immune response to antigens
granted -
US 9539340
Bladder cancer specific ligand peptides
granted -
US 9539300
Modulating disease through genetic engineering of plants
granted -
US 9532994
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
granted -
US 9534033
Targeted interferons demonstrating potent apoptotic and anti-tumor activities
granted -
US 9535076
Methods and compositions for eliciting an amyloid-selective immune response
granted -
US 9527919
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
granted -
US 9528994
Target of the phosphoinositide 3-kinase pathway
granted -
US 9529001
Methods of diagnosing and treating autism
granted